Furthermore, treatment with ONP-302 followed by anti-PD-1 induced a significant increase in the percentage of activated CD8+ and IFN-γ+ T cells within the tumor, hallmarks of effective anti-PD-1 treatment. The gene discussed is CD8A; the disease is neoplasm.